Lifeward (LFWD) Net Income towards Common Stockholders (2015 - 2026)

Lifeward's (LFWD) quarterly Net Income towards Common Stockholders came in at -$10.8 million in Q1 2026, down 123.27% year-on-year from $46.4 million in Q1 2025, and down 101.81% quarter-over-quarter from -$5.3 million in Q4 2025.

Lifeward (LFWD) Net Income towards Common Stockholders (2015 - 2026) Analysis & Trends

Lifeward has disclosed Net Income towards Common Stockholders across 12 years of filings, most recently posting -$10.8 million for Q1 2026.

  • Net Income towards Common Stockholders for Q1 2026 came in at -$10.8 million, down 123.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$25.9 million (up 5.92% YoY), and the FY2025 annual result was -$19.9 million, up 31.19% from the prior year.
  • Net Income towards Common Stockholders came in at -$10.8 million for Q1 2026 at Lifeward, down from -$5.3 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$3.1 million in Q3 2024 to a low of -$15.3 million in Q4 2024.
  • The 5-year median for Net Income towards Common Stockholders is -$5.3 million (2022), against an average of -$6.0 million.
  • Across the five-year window, Net Income towards Common Stockholders sank 170.93% in 2024 and jumped 65.0% in 2025, its largest moves.
  • Lifeward's Net Income towards Common Stockholders stood at -$5.3 million in 2022, then slipped by 6.14% to -$5.6 million in 2023, then tumbled by 170.93% to -$15.3 million in 2024, then surged by 65.0% to -$5.3 million in 2025, then plunged by 101.81% to -$10.8 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$10.8 million (Q1 2026), -$5.3 million (Q4 2025), and -$3.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.08 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 745.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 411.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 199.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Lifeward 11.33 Mn -74,887.59 1.34 Mn -10.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.79 Mn
Dec 31, 2025 -5.35 Mn
Sep 30, 2025 -3.17 Mn
Jun 30, 2025 -6.56 Mn
Mar 31, 2025 -4.83 Mn
Dec 31, 2024 -15.28 Mn
Sep 30, 2024 -3.08 Mn
Jun 30, 2024 -4.30 Mn
Mar 31, 2024 -6.28 Mn
Dec 31, 2023 -5.64 Mn
Sep 30, 2023 -7.53 Mn
Jun 30, 2023 -4.64 Mn
Mar 31, 2023 -4.32 Mn
Dec 31, 2022 -5.31 Mn
Sep 30, 2022 -5.46 Mn
Jun 30, 2022 -4.45 Mn
Mar 31, 2022 -4.35 Mn
Dec 31, 2021 -3.86 Mn
Sep 30, 2021 -2.68 Mn
Jun 30, 2021 -3.14 Mn